Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs dexmedetomidine for surgeon satisfaction and bleeding in rhinoplasty
IRCT20141009019470N112Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in None comparing Remifentanil arm with Dexmedetomidine arm (2 arms). Primary endpoints: Surgeon satisfaction with surgical field and Intraoperative bleeding. Started Apr 2021; status: completed.
02
Drugs
remifentanildexmedetomidine
Beyond the preview
Go deeper on IRCT20141009019470N112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N112.